Physician profile
Grace Collupy
NPI 1417140344
$333.70
in general payments reported to CMS, 2019-2025
11 companies · $106 in 2025
The $106 reported for 2025 was more than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $88.59 · 2023: $117 · 2024: $22.47 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $51.65 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Myriad Women'S Health, INC. | $48.49 | 2023 | Myrisk |
| Shield Therapeutics INC | $41.31 | 2023-2024 | |
| Mayne Pharma Commercial LLC | $35.04 | 2022-2025 | |
| Abbvie INC. | $33.95 | 2023 | |
| Exeltis, USA INC. | $27.52 | 2022-2023 | Slynd |
| Scynexis, INC. | $25.74 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.16 | 2025 | |
| Organon LLC | $17.42 | 2025 | Jada System |
| Pacira Pharmaceuticals Incorporated | $17.18 | 2022 | |
| Avion Pharmaceuticals | $14.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Collupy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.